Results 41 to 50 of about 15,859 (208)

Predictive factors for oligometastatic versus non-oligometastatic involvement of the central nervous system by brain metastases from breast cancer.

open access: yes, 2011
123 Background: To assess rates of oligometastatic (1-3 metastases) versus non-oligometastatic (4 or more) involvement of the central nervous system (CNS) from breast cancer and determine whether rates vary for different breast cancer subtypes ...
R. D. Rao   +3 more
core   +1 more source

Oligometastatic Disease: When Stage IV Breast Cancer Could Be “Cured”

open access: yes, 2022
Although metastatic breast cancer remains an incurable disease, there are patients with a limited number of metastatic lesions that, in addition to systemic therapy, can be treated with “radical therapy” and sometimes reach the status of no long-term ...
Gion, Maria   +7 more
core   +1 more source

Radiotherapy for Oligometastatic Lung Cancer [PDF]

open access: yesFrontiers in Oncology, 2017
Non-small cell lung cancer (NSCLC) typically presents at an advanced stage, which is often felt to be incurable, and such patients are usually treated with a palliative approach. Accumulating retrospective and prospective clinical evidence, including a recently completed randomized trial, support the existence of an oligometastatic disease state ...
Bergsma, Derek P.   +4 more
openaire   +3 more sources

Pattern of Failure in Nasopharyngeal Carcinoma After Radiotherapy in a Low‐Incidence Population: A DAHANCA Study

open access: yesHead &Neck, EarlyView.
ABSTRACT Background Nasopharyngeal carcinoma (NPC) is uncommon in many populations. Most existing clinical evidence comes from endemic areas, where Epstein–Barr virus (EBV)‐associated subtypes predominate. We analyzed patterns of failure in a population‐based cohort from Denmark, a low‐incidence setting.
Anne Marie Lindegaard   +14 more
wiley   +1 more source

Modern approach in oligometastatic prostate cancer therapy [PDF]

open access: yesMedicinski Podmladak, 2023
Oligometastatic disease is defined as an intermediate state between localized and widespread metastatic disease. Oligometastatic prostate cancer is generally defined by the presence of five or fewer metastatic sites on imaging.
Stanić Jelena   +3 more
doaj  

MicroRNA expression characterizes oligometastasis(es). [PDF]

open access: yesPLoS ONE, 2011
Cancer staging and treatment presumes a division into localized or metastatic disease. We proposed an intermediate state defined by ≤ 5 cumulative metastasis(es), termed oligometastases.
Yves A Lussier   +19 more
doaj   +1 more source

When Explant Surprises: Management and Outcomes of Hepatocellular Carcinoma Beyond Milan Criteria Discovered Post‐Transplant‐ A Narrative Review of Literature

open access: yesJournal of Surgical Oncology, EarlyView.
ABSTRACT Liver transplantation (LT) is the definitive treatment for early hepatocellular carcinoma (HCC), based on established criteria. Pre‐transplant imaging occasionally underestimates the tumor burden or biological aggressiveness, leading to explant pathology that exceeds the projection criteria, such as Milan.
Serkan Sucu   +2 more
wiley   +1 more source

Salvage Operation in Case of Oligometastatic Disease [PDF]

open access: yesThe Annals of Thoracic Surgery, 2017
In general, prognosis of stage IV non-small cell lung cancer is poor, and treatment is mostly palliative. However, oligometastatic disease is currently recognized as a specific entity with a better prognosis. We report a patient where combined chemoradiotherapy and salvage surgery led to extraordinary long-term survival.
Duchateau, Nicolas   +2 more
openaire   +3 more sources

First multicentre experience of SABR for lymph node and liver oligometastatic disease on the unity MR-Linac [PDF]

open access: yes, 2022
The treatment of oligometastatic disease using MR guidance is an evolving field. Since August 2018 patients are treated on a 1.5 Tesla MR-Linac (MRL). We present current workflows and practice standards from seven institutions for the initial patients ...
On Behalf of the tumor site group for oligometastatic disease of the Elekta MR-Linac Consortium   +4 more
core  

Australian Practical Guide on the Management of Muscle‐Invasive Bladder Cancer

open access: yesAsia-Pacific Journal of Clinical Oncology, EarlyView.
Australia's management of muscle‐invasive bladder cancer is evolving, with increased use of perioperative therapy and emerging immunotherapies. However, challenges such as cisplatin ineligibility, limited access, and costs persist. Expanding bladder‐sparing approaches, precision medicine, and integrated care pathways will be key to improving outcomes ...
Dickon Hayne   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy